Results 261 to 270 of about 6,853,200 (317)

Combination Drug Therapy for Familial Combined Hyperlipidemia

Annals of Internal Medicine, 1988
To compare the efficacy of gemfibrozil and colestipol with gemfibrozil and lovastatin in patients with familial combined hyperlipidemia.A prospective, randomized trial.An outpatient clinical research center in a tertiary care center.Seventeen patients with familial combined hyperlipidemia documented by studies of first-degree relatives; nine patients ...
C, East, D W, Bilheimer, S M, Grundy
openaire   +2 more sources

Combination drug therapy for combined hyperlipidemia

Current Cardiology Reports, 1999
Combination therapy for hyperlipidemia, especially combined hyperlipidemia, may have advantages over single drug therapy, affording better improvement in lipoprotein risk factors and possibly better prevention of atherothrombotic events. Although preliminary experience has been gained using treatment combinations of niacin with statins, and fibrates ...
openaire   +2 more sources

Fixed Combination Drug Therapy

Drugs, 1982
Almost half of all marketed drugs are fixed combination preparations, yet the World Health Organization included only 7 in its list of 240 "essential' drugs. There has been little scientific study of these preparations but much emotion and rhetoric has been expended both for and against them.
openaire   +2 more sources

Combination drug–diet therapies for dyslipidemia

Translational Research, 2010
Expense, high drug dose, and low compliance to strict dietary therapies are current issues surrounding modern drug- and diet-based lipid-lowering approaches. Furthermore, variable patient outcomes and suboptimal response to both drug and diet therapies are increasingly evident. Therefore, the question arises as to whether more emphasis should be placed
Rideout, Todd C, Harding, Scott V, Marinangeli, Christopher P F, Jones, Peter J H   +3 more
openaire   +3 more sources

Problems of Combination Drug Therapy in Children

Epilepsia, 1988
Summary: Despite the current trend toward monotherapy, polytherapy in children with epilepsy is still common. A drug combination is advantageous only if it achieves a higher efficacy: toxicity ratio (therapeutic index) or if its antiepileptic spectrum is wider.
openaire   +2 more sources

Drug Combinations as Rational Antihypertensive Therapy

Archives of Internal Medicine, 1974
The goal of antihypertensive therapy is to restore blood pressure to normal with as few side effects as possible. Usually this is best accomplished by skillfully combining two or more drugs in the regimen. A diuretic should be the cornerstone on which the regimen is built; for many patients with mild hypertension, a diuretic will be the only drug ...
openaire   +2 more sources

Combination Drug Therapy for Hypercholesterolemia

Archives of Internal Medicine, 1993
Background: The National Cholesterol Education Program recommends achievement of a defined target level of low-density lipoprotein cholesterol (LDL-C) for the treatment of hypercholesterolemia. They endorse the use of niacin and/or sequestrants as the first line of therapy to achieve such target LDL-C level.
openaire   +1 more source

Combination drug therapy for dyslipidaemia

Current Opinion in Lipidology, 1993
The use of combination therapy with lipid-lowering agents which have complementary effects on lipoprotein metabolism is an important option for the treatment of severe hyperlipoproteinaemia. This review presents a discussion of recent studies of combination therapy set against the background of existing knowledge in this important therapeutic area.
openaire   +1 more source

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Shanu Modi, Cortes J, Roberto Carmagnani Pestana   +2 more
exaly  

SynergyFinder Plus: Toward Better Interpretation and Annotation of Drug Combination Screening Datasets

Genomics, Proteomics and Bioinformatics, 2022
Jing Tang, Alina Malyutina, Alberto Pessia   +2 more
exaly